1. Home
  2. RVSN vs INBS Comparison

RVSN vs INBS Comparison

Compare RVSN & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rail Vision Ltd.

RVSN

Rail Vision Ltd.

HOLD

Current Price

$1.79

Market Cap

7.9M

Sector

N/A

ML Signal

HOLD

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

SELL

Current Price

$1.39

Market Cap

6.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RVSN
INBS
Founded
2016
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9M
6.5M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
RVSN
INBS
Price
$1.79
$1.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.0K
★ 34.1K
Earning Date
08-26-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,980,484.00
Revenue This Year
$169.00
$44.72
Revenue Next Year
N/A
$44.26
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.54
52 Week High
$9.39
$24.90

Technical Indicators

Market Signals
Indicator
RVSN
INBS
Relative Strength Index (RSI) 23.56 36.82
Support Level N/A N/A
Resistance Level $2.99 $1.86
Average True Range (ATR) 0.24 0.18
MACD -0.06 -0.06
Stochastic Oscillator 6.71 1.04

Price Performance

Historical Comparison
RVSN
INBS

About RVSN Rail Vision Ltd.

Rail Vision Ltd is an early commercialization stage technology company focused on railway safety systems using AI-integrated sensing systems. The company develops and commercializes proprietary, multi-spectral electro-optic platforms that provide extended-range situational awareness and real-time hazard detection. Using machine learning algorithms to identify and classify obstacles, the company's technology enhances safety, improves operational efficiency, and supports continuity across deployments.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

Share on Social Networks: